Search results
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 4 days agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Low Risk for New-Onset Thyroid Diseases After mRNA Vaccines
MedPage Today· 6 days agoThe chance of new-onset thyroid disease after administration of mRNA COVID-19 vaccines was rare, but...
Pandemic treaty talks in Geneva get one final big push
The Telegraph via Yahoo News· 59 minutes agoThey think it’s all over, but it’s not quite. Representatives of the 194 member states of the World...
What’s driving the anti-vax movement? | The Excerpt
USA TODAY via Yahoo News· 5 days agoAnd I said, my whole life, 79 years of my life, I have been dealing with this now, and now with post-polio syndrome, I have more challenges. I have a sign that's on the back ...
Scope of practice expands for Tennessee pharmacists
Becker’s Hospital Review· 1 day agoBill Lee signed a bill into law that expands pharmacists' scope of practice. Tennessee pharmacists can now prescribe flu and COVID-19 antivirals after a ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 4 days agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 5 days agoNovavax retains its pipeline rights and could earn substantial royalties from Sanofi's development...
Map shows whooping cough hotspots as 'worst outbreak in 40 years' kills 5 babies
The US Sun· 2 days agoA MAP reveals whooping cough hotspots across England and Wales - after reports that five babies died...
‘A Governor Who Doesn’t Seem to Have Much Interest in Governing Arkansas’
Politico via Yahoo News· 5 hours ago“Sanders is certainly her own person. She’s a very strong personality,” he told me. She was also incredibly well-funded, with money surging in from out of state. Sanders’ primary challenger ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 4 days agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...